The new study showed that implanting stem cells that produce neurotrophic factors (MSC-NTF) into either muscle or the intrathecal space surrounding the spinal cord, or both, after 6 months were shown to be safe and associated with only mild and transient adverse effects, principally headache and fever. Read more here.…
We are excited to report that the PRO-ACT database is growing- Six new trials were added to the database, which now includes 23 trials and data from over 10,700 patients! The database is available for researchers on www.ALSDatabase.org …
Congratulations to NEALS Co-Chair Dr. Terry Heiman-Patterson for winning this year's prestigious Forbes Norris Award!
More than 800 researchers, clinicians, and patients with ALS gathered in balmy Orlando, Florida, on December 11-13, for the 26th International Symposium on ALS/MND. Read more here.…
Patients with amyotrophic lateral sclerosis (ALS) often have periods of stable disease, with some even experiencing brief improvements, shows analysis of the PRO-ACT database. Read more here.…
Presented at the 26th International Symposium on ALS/MND in Orlando, FL. Read more here.…
Successful dose and confirmatory study solid platform for phase II/III trial in ALS patients. Read more here.…
Treeway is pleased to announce a collaboration with the Cedars-‐Sinai Board of Governors Regenerative Medicine Institute for the development of AAV5-‐GDNF (TW002) gene therapy for ALS. Read more here.…
"The NFL has had 1000s of game changers, ALS only needs 1." Watch here.…
Bedlack founded and directs Duke University’s ALS Clinic, which takes an unusual interdisciplinary approach to helping ease the suffering and extend the lives of patients with this fatal disease. Read more here.…
